September 26, 2018, Wednesday
The stock hit a new high of Rs 718, rallying 8% in two days after the company's drug substance manufacturing site at Bengaluru campus by the US ...
September 25, 2018, Tuesday
The announcement of the successor will be made shortly, said the company in a regulatory filing
September 22, 2018, Saturday
The CHMP opinion for the drug to be sold under the named Fulphila will now be considered by the European Commission and the decision on approval ...
September 21, 2018, Friday
The National Company Law Tribunal (NCLT), Chennai Bench has approved the resolution plan submitted by US-based investor Ingen Capital Group LLC ...
September 21, 2018, Friday
The initial public offer (IPO) is expected to fetch Rs 4.5 billion
September 21, 2018, Friday
ILUMYA is one of the key specialty products of Sun Pharma and it was approved by the US health regulator USFDA in March 2018 while the European ...
September 20, 2018, Thursday
With the Max Healthcare deal, Radiant would have access to 14 hospitals led by Max
September 19, 2018, Wednesday
At the 14th AGM, RCom Chairman Anil Ambani announced that the company will exit telecom business completely, owing to intense slugfest in the ...
September 17, 2018, Monday
SC did not grant any relief to the other medicines in the list of 328 FDC drugs, which were banned by the Health Ministry by its September 7 ...
September 17, 2018, Monday
The approved product is a generic version of Novo Nordisk Inc's VAGIFEM
September 17, 2018, Monday
Of over 140 products in pipeline, at least 10 are para IV filings
September 15, 2018, Saturday
The Ranbaxy-Daiichi issue - all emerged within one year. I said I had taken a one-way ticket to Beas and was not interested, but, then, because ...
September 15, 2018, Saturday
The top seven brands have together grown at 21 per cent annually and now account for 46 per cent of Sanofi's sales
September 14, 2018, Friday
Sun Pharma rose over 3 per cent to an intra-day high of Rs 670.90 on the NSE after the drug maker announced USFDA approval of XELPROS to treat ...
September 13, 2018, Thursday
Their mother has acted as the peacemaker, however, Shivinder might take legal route again if the conflict is not resolved through mediation
September 12, 2018, Wednesday
As per IQVIA MAT June 2018 data, Atovaquone oral suspension, 750 mg/5 mL had annual sales of around $117.4 million in the US
September 12, 2018, Wednesday
The stock has moved higher by 4% to Rs 655, bouncing back 6% from its early morning low of Rs 620 on the BSE on Wednesday.
September 12, 2018, Wednesday
This addition of new beds would add to the already existing 10,000 beds it has across 70 hospitals
September 12, 2018, Wednesday
Sun Pharma said the US health regulator USFDA was conducting an inspection of its Mohali facility in Punjab.
September 11, 2018, Tuesday
The stock hit a new high of Rs 830, up 10% in the intraday trade today, rallied 103% from Rs 408 on August 7, as compared to 0.58% rise in the ...
September 11, 2018, Tuesday
The stock hit a 52-week high of Rs 338, rallied 88% in past four months, trading close to its record high of Rs 339 touched on April 15, 2015 on ...
September 11, 2018, Tuesday
Sun Pharma has agreed to acquire 18.75 per cent shares of Israel-based Tarsius Pharma for a cash consideration of $3 million (over Rs 21 crore).
September 10, 2018, Monday
Opted for at early stage, the therapy could avoid a hip or knee replacement; firm has applied for clinical trials in US, EU
September 10, 2018, Monday
The company has already launched this product in Denmark, Sweden and Norway
September 08, 2018, Saturday
Halol, a key plant for the drug maker to manufacture injectables and specialty drugs, was under regulatory scanner since 2014
September 07, 2018, Friday
Shares of Sun Pharmaceutical Industries on Friday closed at Rs 664.20 per scrip on BSE, down 1.84 per cent from its close
September 07, 2018, Friday
The stock hit an intra-day high of Rs 670, recovering 4.7% from its early morning low of Rs 640 on the NSE.
September 07, 2018, Friday
Aurobindo Pharma was up 9% at Rs 826, surging 22% in past three trading days after the company on Thursday announced the acquisition of Sandoz's ...
September 07, 2018, Friday
In past three months, Sun Pharma had outperformed the market by surging 38% as compared to a 9% rise in the benchmark index till Thursday.
September 07, 2018, Friday
Attractive valuations, large portfolio add to growth pipeline, keep leverage ratios moderate
September 06, 2018, Thursday
Granules India, Hikal, Pfizer, Lincoln Pharmaceuticals, Astrazeneca Pharma India and Aarti Drugs were up between 4% and 7%.
September 06, 2018, Thursday
Shivinder's counsel asks court to disallow any sale of shares in RHC Holdings by elder brother Malvinder
September 06, 2018, Thursday
The stock rallied 5% to Rs 732 on Thursday, extending its Wednesday's 2% gain on the BSE, after the company announced the acquisition of ...
September 06, 2018, Thursday
The deal gives the Hyderabad based company access to Sandoz's portfolio of oral solids and dermatology drugs and manufacturing footprint
September 06, 2018, Thursday
At NCLT, Shivinder pleads to remove brother from RHC Holding's board
September 05, 2018, Wednesday
In a petition filed before NCLT, Shivinder sued Malvinder for 'oppression and mismanagement' of their companies.
September 05, 2018, Wednesday
The tablets, used to treat hypokalemia, will be available in 600 mg and 750 mg dosage
September 05, 2018, Wednesday
The stock locked in the lower circuit for the second straight day, down 5% at Rs 3,064 on the BSE.
September 04, 2018, Tuesday
The government has accepted the proposal but has decided to form state-level committees
September 04, 2018, Tuesday
Says also taken Sunil Godhwani to NCLT; adds that red flags had crept up with disturbing regularity in managing family businesses pointing to ...
September 04, 2018, Tuesday
Hikal hits 52-week high of Rs 192, up 4% on Tuesday, extending its previous day's 15% surge on the National Stock Exchange.
